ArticleFrontiers in pharmacology2021

Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway.

Yingchun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.